Page last updated: 2024-11-02

pimobendan and Myocardial Ischemia

pimobendan has been researched along with Myocardial Ischemia in 5 studies

pimobendan: produces arterial & venous dilatation in dogs; structure given in first source

Myocardial Ischemia: A disorder of cardiac function caused by insufficient blood flow to the muscle tissue of the heart. The decreased blood flow may be due to narrowing of the coronary arteries (CORONARY ARTERY DISEASE), to obstruction by a thrombus (CORONARY THROMBOSIS), or less commonly, to diffuse narrowing of arterioles and other small vessels within the heart. Severe interruption of the blood supply to the myocardial tissue may result in necrosis of cardiac muscle (MYOCARDIAL INFARCTION).

Research Excerpts

ExcerptRelevanceReference
"In contrast to cyclic AMP-dependent positive inotropes, the calcium-sensitizer and partial phosphodiesterase (PDE) inhibitor pimobendan may induce beneficial effects in heart failure."9.07Hemodynamic, neurohumoral, and myocardial energetic effects of pimobendan, a novel calcium-sensitizing compound, in patients with mild to moderate heart failure. ( Bartels, GL; de Leeuw, PW; Krauss, XH; Kruijssen, DA; Remme, WJ; Storm, CJ; van Hoogenhuyze, DC, 1994)
"In contrast to cyclic AMP-dependent positive inotropes, the calcium-sensitizer and partial phosphodiesterase (PDE) inhibitor pimobendan may induce beneficial effects in heart failure."5.07Hemodynamic, neurohumoral, and myocardial energetic effects of pimobendan, a novel calcium-sensitizing compound, in patients with mild to moderate heart failure. ( Bartels, GL; de Leeuw, PW; Krauss, XH; Kruijssen, DA; Remme, WJ; Storm, CJ; van Hoogenhuyze, DC, 1994)
"Pimobendan is a drug with positive inotropic effects that additionally inhibits the production of proinflammatory cytokines."2.42The role of Ca++-sensitizers for the treatment of heart failure. ( Boldt, J; Kirchner, J; Lehmann, A, 2003)
"Pretreatment with rolipram decreased the duration of ventricular tachycardia without any change in the incidences of dysrhythmias or the mortality rate."1.32Effects of rolipram, pimobendan and zaprinast on ischaemia-induced dysrhythmias and on ventricular cyclic nucleotide content in the anaesthetized rat. ( Aleixandre, F; Carceles, MD; Fuente, T; Laorden, ML; López-Vidal, J, 2003)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (60.00)18.2507
2000's2 (40.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Carceles, MD1
Aleixandre, F1
Fuente, T1
López-Vidal, J1
Laorden, ML1
Lehmann, A1
Boldt, J1
Kirchner, J1
Hagemeijer, F1
Remme, WJ1
Kruijssen, DA1
van Hoogenhuyze, DC1
Krauss, XH1
Bartels, GL1
Storm, CJ1
de Leeuw, PW1
Abe, Y1
Sekioka, K1
Ishisu, R1
Onishi, K1
Ueda, Y1
Nakano, T1

Reviews

1 review available for pimobendan and Myocardial Ischemia

ArticleYear
The role of Ca++-sensitizers for the treatment of heart failure.
    Current opinion in critical care, 2003, Volume: 9, Issue:5

    Topics: Calcium; Cardiotonic Agents; Chronic Disease; Clinical Trials as Topic; Dobutamine; Heart Failure; H

2003

Trials

1 trial available for pimobendan and Myocardial Ischemia

ArticleYear
Hemodynamic, neurohumoral, and myocardial energetic effects of pimobendan, a novel calcium-sensitizing compound, in patients with mild to moderate heart failure.
    Journal of cardiovascular pharmacology, 1994, Volume: 24, Issue:5

    Topics: Adult; Aged; Blood Pressure; Cardiac Output; Cardiotonic Agents; Catecholamines; Coronary Angiograph

1994

Other Studies

3 other studies available for pimobendan and Myocardial Ischemia

ArticleYear
Effects of rolipram, pimobendan and zaprinast on ischaemia-induced dysrhythmias and on ventricular cyclic nucleotide content in the anaesthetized rat.
    European journal of anaesthesiology, 2003, Volume: 20, Issue:3

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 3',5'-Cyclic-GMP Phosphodiesterases; Anesthesia; Animals; Arrhy

2003
Hemodynamic performance during exercise in patients with severe chronic congestive heart failure before and after a single dose of pimobendan.
    Journal of cardiovascular pharmacology, 1994, Volume: 23, Issue:5

    Topics: Administration, Oral; Aged; Cardiomyopathy, Dilated; Cardiotonic Agents; Child; Exercise; Female; He

1994
Restoration of ischemic contractile failure of indo-1-loaded guinea pig heart by a calcium sensitizer, MCI-154.
    The Journal of pharmacology and experimental therapeutics, 1996, Volume: 279, Issue:1

    Topics: Animals; Calcium; Cardiotonic Agents; Guinea Pigs; Indoles; Male; Myocardial Contraction; Myocardial

1996